(January 20, 2017) OCRFA has awarded $5.6 million in new scientific research grants for ovarian cancer, bringing our total investment in life-saving research to over $75 million. This year’s grants … Continued
OCRFA’s Community Partners (formerly called Partner Members) are outstanding grassroots, local and national organizations around the country who share a commitment to eradicate ovarian cancer through research, advocacy, support, education … Continued
Time is running out to make your tax-deductible 2016 gift to OCRFA. We need your help. Over 22,000 women will be diagnosed with ovarian cancer in 2017. Over 200,000 women … Continued
Every year, 22,000 women are newly diagnosed with ovarian cancer. As OCRFA strives toward a cure and better treatments through research, we also provide patients and survivors with the care … Continued
As the voice for women with ovarian cancer on Capitol Hill, OCRFA fights to secure funding for ovarian cancer research and education at the federal level. In 2016, with the … Continued
OCRFA-funded scientists are working hard to save women’s lives. In medical institutions across the country, they investigate the origins and biology of ovarian cancer, find new ways to identify and … Continued
OCRFA recently welcomed four new members to the Scientific Advisory Committee (SAC), our world-class group of leaders in the ovarian cancer field who review and approve all OCRFA research grants. … Continued
(Nov. 3, 2016) Senescence is the state when normal, healthy cells no longer have the ability to divide, which can occur during chemotherapy or when cancer genes within that cell … Continued
(October 31, 2016) Estrogen signaling is a known factor in how certain estrogen receptive (ER positive) tumors grow in breast and ovarian cancers. That signaling, which can promote malignant tumor … Continued
We’re excited to announce that OCRFA’s new and refreshed website is live. The new site is reflective of the merger of Ovarian Cancer Research Fund and the Ovarian Cancer National … Continued
On September 7th, the FDA issued an important safety communication about tests marketed as ovarian cancer screening tests, including the ROCA Test developed by Abcodia Incorporated. The FDA states, “despite extensive … Continued
Meet a Researcher: We had the chance to interview Dr. Hui Shen, a 2016 Liz Tilberis Early Career Award grantee to get to know her! Read our interview here. OCRFA: … Continued
Get email updates about research news, action alerts, and ways to join the fight.
